Nordic Nanovector ASA (0R6Y)

London
Currency in NOK
2.61
-0.02(-0.76%)
Closed
0R6Y Scorecard
Full Analysis
Stock generally trades with high price volatility
Fair Value
Day's Range
2.612.61
52 wk Range
0.874.41
Key Statistics
Edit
Bid/Ask
2.48 / 2.74
Prev. Close
2.63
Open
2.61
Day's Range
2.61-2.61
52 wk Range
0.87-4.41
Volume
-
Average Volume (3m)
22.14K
1-Year Change
114.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0R6Y Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Thor Medical ASA Company Profile

As of July 3, 2023, Nordic Nanovector ASA was acquired by Thor Medical AS, in a reverse merger transaction. Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company’s lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin’s lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Compare 0R6Y to Peers and Sector

Metrics to compare
0R6Y
Peers
Sector
Relationship
P/E Ratio
−33.5x−2.1x−0.6x
PEG Ratio
-−0.020.00
Price/Book
2.4x1.4x2.6x
Price / LTM Sales
-12.8x3.1x
Upside (Analyst Target)
-124.6%53.6%
Fair Value Upside
Unlock12.1%8.0%Unlock

Earnings

Latest Release
Nov 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

102.60
AUSS
+0.49%
25.40
SATSS
+0.20%
73.85
EPR
+0.61%
18.36
MPCC
-2.55%
125.70
STB
+0.88%

FAQ

What Is the Thor Medical (0R6Y) Stock Price Today?

The Thor Medical stock price today is 2.61

What Stock Exchange Does Thor Medical Trade On?

Thor Medical is listed and trades on the London stock exchange.

What Is the Stock Symbol for Thor Medical?

The stock symbol for Thor Medical is "0R6Y."

What Is the Thor Medical Market Cap?

As of today, Thor Medical market cap is 622.38M.

What is Thor Medical Earnings Per Share?

The Thor Medical EPS is -0.152.

What Is the Next Thor Medical Earnings Date?

Thor Medical will release its next earnings report on 26 Feb 2025.

From a Technical Analysis Perspective, Is 0R6Y a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.